Patterns of Use and Reasons for Discontinuation of Prophylactic Medications for Episodic Migraine and Chronic Migraine: Results From the Second International Burden of Migraine Study (IBMS-II)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Patterns of Use and Reasons for Discontinuation of Prophylactic Medications for Episodic Migraine and Chronic Migraine: Results From the Second International Burden of Migraine Study (IBMS-II)

Published:2013-03-04 Issue:4 Volume:53 Page:644-655
ISSN:0017-8748
Container-title:Headache: The Journal of Head and Face Pain
language:en
Short-container-title:Headache: The Journal of Head and Face Pain

Author:

Blumenfeld Andrew M.¹,Bloudek Lisa M.²,Becker Werner J.³,Buse Dawn C.⁴,Varon Sepideh F.²,Maglinte Gregory A.²,Wilcox Teresa K.⁵,Kawata Ariane K.⁵,Lipton Richard B.⁴

Affiliation:

1. Neurology Center; Encinitas; CA; USA

2. Allergan Inc.; Irvine; CA; USA

3. University of Calgary; Calgary; AB; Canada

4. Albert Einstein College of Medicine and the Montefiore Headache Center; Bronx; NY; USA

5. United BioSource Corporation; Bethesda; MD; USA

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/head.12055/fullpdf

Reference14 articles.

1. Economic burden of transformed migraine: Results from the American Migraine Prevalence and Prevention (AMPP) Study;Munakata;Headache,2009

2. Chronic migraine in the population: Burden, diagnosis, and satisfaction with treatment;Bigal;Neurology,2008

3. Migraine prevalence, disease burden, and the need for preventive therapy;Lipton;Neurology,2007

4. Prevalence of migraine headache in Canada: A population-based survey;O'Brien;Int J Epidemiol,1994

5. The global burden of headache: A documentation of headache prevalence and disability worldwide;Stovner;Cephalalgia,2007

Cited by 308 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost per treatment responder analysis of atogepant compared to rimegepant for the preventive treatment of episodic migraine;Headache: The Journal of Head and Face Pain;2024-09-09

2. Enhancing chronic migraine preventive therapy: low-level 810 nm laser acupuncture as an add-on treatment for patients with unsatisfactory pharmacological effect, a pilot single-blind randomized controlled trial;BMC Complementary Medicine and Therapies;2024-08-28

3. Erenumab versus topiramate: migraine‐related disability, impact and health‐related quality of life;European Journal of Neurology;2024-08-12

4. Treatment patterns of patients with migraine eligible for anti-CGRP pathway monoclonal antibodies;Frontiers in Neurology;2024-08-06

5. Successful treatment with traditional Japanese medicine (kampo medicine) Yokukansan as a migraine prophylactic drug: A case report;Medicine;2024-07-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3